Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients | Zendy

Jordi Navarro | Zendy; Montserrat Laguno | Zendy; Helem Vílchez | Zendy; José M. Guardiola | Zendy; J.A. Carrión | Zendy; Luís Force | Zendy; Mireia Cairó | Zendy; Carmen Luna | Zendy; Josep Vilaró | Zendy; Josep Cucurull | Zendy; Andrés Marco | Zendy; Mercè Roget | Zendy; Eva Erice | Zendy; Manuel Crespo | Zendy; Jordí Ortiz | Zendy; Carla Aparicio | Zendy; Josep Mallolas | Zendy; Maria Martínez Rebollar | Zendy; Marc Puigvehí | Zendy; Pilar Barrufet | Zendy; Glòria Sempere | Zendy; Josep M. Guardiola | Zendy; Mercè PérezRiba | Zendy; C Sarriera | Zendy; Imma Valls | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients

Author(s) -

Jordi Navarro,

Montserrat Laguno,

Helem Vílchez,

José M. Guardiola,

J.A. Carrión,

Luís Force,

Mireia Cairó,

Carmen Luna,

Josep Vilaró,

Josep Cucurull,

Andrés Marco,

Mercè Roget,

Eva Erice,

Manuel Crespo,

Jordí Ortiz,

Carla Aparicio,

Josep Mallolas,

Maria Martínez Rebollar,

Marc Puigvehí,

Pilar Barrufet,

Glòria Sempere,

Josep M. Guardiola,

Mercè PérezRiba,

C Sarriera,

Imma Valls

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx223

Subject(s) - sofosbuvir , ledipasvir , medicine , daclatasvir , simeprevir , ribavirin , tolerability , gastroenterology , hepatitis c , ritonavir , cirrhosis , decompensation , adverse effect , hepatitis c virus , virology , viral load , human immunodeficiency virus (hiv) , virus , antiretroviral therapy

New direct-acting antiviral agents (DAAs) have shown great efficacy and tolerability in clinical trials and real-life cohorts. However, data are scarce regarding efficacy and safety in cirrhotic HCV/HIV-coinfected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research